Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 16INDUSTRY 12NIH 2NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Astrocytoma 29Central Nervous System Neoplasms 28Unspecified Adult Solid Tumor, Protocol Specific 18Ovarian Neoplasms 17Oligodendroglioma 17Medulloblastoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lung Neoplasms 15Optic Nerve Glioma 14Neuroblastoma 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 14Leukemia 13Glioblastoma 13Familial ependymoma 12Choroid Plexus Neoplasms 12Carcinoma, Ovarian Epithelial 12Fallopian Tube Neoplasms 11Burkitt Lymphoma 11Breast Neoplasms 11Sarcoma 10Colorectal Neoplasms 9Brain Neoplasms 9Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Brenner Tumor 8Lymphoma, Non-Hodgkin 7Glioma 7Colonic Neoplasms 7Uterine Cervical Neoplasms 6

Interventions

imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Lymphoproliferative Disorders × Clear all
NCT01273090 2014-01-30

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Children's Oncology Group

Phase 1 Completed
34 enrolled
CNSDermatologicLymphoidSarcoma

Astrocytoma, Burkitt Lymphoma, Glioblastoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Mycosis Fungoides, Oligodendroglioma, Recurrence, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Neoplasms, Neuroepithelial, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡